 
                        | Product NDC: | 51079-412 | 
| Proprietary Name: | Atorvastatin Calcium | 
| Non Proprietary Name: | atorvastatin calcium | 
| Active Ingredient(s): | 80 mg/1 & nbsp; atorvastatin calcium | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 51079-412 | 
| Labeler Name: | Mylan Institutional Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA091226 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20121227 | 
| Package NDC: | 51079-412-03 | 
| Package Description: | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-412-03) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-412-01) | 
| NDC Code | 51079-412-03 | 
| Proprietary Name | Atorvastatin Calcium | 
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-412-03) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-412-01) | 
| Product NDC | 51079-412 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | atorvastatin calcium | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20121227 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Mylan Institutional Inc. | 
| Substance Name | ATORVASTATIN CALCIUM | 
| Strength Number | 80 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |